You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0852 Increased infection rate with concomitant rank ligand inhibitor denosumab and biologic therapies for rheumatic diseases: reality or illusion? experience with 40 patients over 66 months at the university of southern california

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Osteoporosis
AB0852 Increased infection rate with concomitant rank ligand inhibitor denosumab and biologic therapies for rheumatic diseases: reality or illusion? experience with 40 patients over 66 months at the university of southern california
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017701
Jul 20172401
Aug 20171001
Sep 20172201
Oct 20171202
Nov 2017600
Dec 2017800
Jan 20181603
Feb 20182400
Mar 2018800
Apr 20182802
May 20181601
Jun 20181200
Jul 20181000
Aug 2018400
Sep 2018400
Nov 20181002
Dec 2018801
Jan 2019200
Feb 2019500
Mar 2019202
Apr 2019103
May 2019201
Jun 2019602
Jul 20191302
Aug 2019103
Sep 2019602
Oct 20191102
Nov 2019203
Dec 2019601
Jan 2020201
Feb 2020503
Mar 2020703
Apr 20202401
May 2020600
Jun 2020603
Jul 2020800
Aug 2020405
Sep 20201600
Oct 2020502
Nov 2020200
Dec 2020800
Jan 2021002
Feb 2021303
Mar 2021703
Apr 2021903
May 2021002
Jun 2021004
Jul 2021004
Aug 2021003
Sep 2021002
Oct 20216013
Nov 202111015
Dec 2021901
Jan 2022200
Feb 2022604
Mar 2022601
Apr 2022601
May 2022907
Jun 20221406
Jul 20221000
Aug 2022605
Sep 20222109
Oct 2022604
Nov 20221000
Dec 2022601
Jan 2023601
Feb 2023400
Mar 20231400
Apr 2023201
May 2023203
Jul 2023404
Aug 2023701
Sep 2023401
Oct 2023001
Nov 2023200
Dec 2023800
Jan 20241000
Feb 2024202
Mar 20242032
Total5930193